Biodesix Inc (BDSX) income statement
BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$8.30−0.10 (-1.19%)
Close on Nov 19, 2026Market cap $87.57MP/E –Yield –
Biodesix Inc financial ratios
See a number that looks wrong?
Close on Nov 19, 2026Market cap $87.57MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Operating margin | -31.5% | -48.4% | -84.2% | -132.4% | -75.1% | -50.3% | -108.9% | – |
| EBITDA margin | -25.1% | -40.3% | -77.4% | -123.0% | -69.3% | -44.0% | -97.5% | – |
| Net profit margin | -39.8% | -60.2% | -106.2% | -171.3% | -79.2% | -143.7% | -125.1% | – |
| Free cash flow margin | -26.6% | -72.7% | -93.3% | -126.3% | -55.9% | -51.2% | -93.8% | – |
| Returns on capital | ||||||||
| Return on equity | -383.1% | -337.3% | -414.1% | -324.5% | -141.8% | 71.1% | 14.6% | – |
| Return on assets | -38.2% | -43.7% | -54.3% | -77.5% | -43.8% | -78.8% | -68.2% | – |
| Return on tangible assets | -48.0% | -55.6% | -71.4% | -109.7% | -60.0% | -119.5% | -206.1% | – |
| Return on invested capital | -77.3% | -122.8% | -411.6% | 12,449.8% | 780.1% | 17.1% | 10.2% | – |
| Return on capital employed | -36.4% | -46.4% | -60.9% | -86.3% | -60.2% | -41.2% | -119.2% | – |
| Return on total capital | -54.5% | -71.1% | -96.8% | -134.3% | -94.3% | 31.8% | 13.3% | – |
| NOPAT | -$22.02M | -$27.25M | -$32.66M | -$39.96M | -$32.34M | -$18.12M | -$21.13M | – |
| Cash flow quality | ||||||||
| OCF / Sales | -26.3% | -68.2% | -46.6% | -117.7% | -51.8% | -46.9% | -88.5% | – |
| OCF / Net income | 0.66 | 1.13 | 0.44 | 0.69 | 0.65 | 0.33 | 0.71 | – |
| FCF / OCF | 101.1% | 106.6% | 200.2% | 107.3% | 107.9% | 109.1% | 106.0% | – |
| FCF / Net income | 0.67 | 1.21 | 0.88 | 0.74 | 0.71 | 0.36 | 0.75 | – |
| FCF / EBITDA | 106.0% | 180.6% | 120.5% | 102.7% | 80.7% | 116.4% | 96.2% | – |
| Unlevered free cash flow | -$17.43M | -$45.36M | -$38.26M | -$41.89M | -$26.90M | -$17.30M | -$20.66M | – |
| Levered free cash flow | -$23.53M | -$51.88M | -$45.79M | -$48.27M | -$30.46M | -$23.31M | -$23.04M | – |
| Efficiency | ||||||||
| Asset turnover | 0.96 | 0.73 | 0.51 | 0.45 | 0.55 | 0.55 | 0.55 | – |
| Fixed asset turnover | 3.36 | 2.56 | 2.91 | 7.62 | 14.82 | 17.20 | 11.58 | – |
| Receivables turnover | 10.03 | 8.76 | 7.70 | 8.76 | 5.75 | 4.42 | 4.64 | – |
| Days sales outstanding | 36.4 | 41.7 | 47.4 | 41.7 | 63.5 | 82.5 | 78.7 | – |
| CapEx to revenue | 0.29% | 4.5% | 46.7% | 8.6% | 4.1% | 4.3% | 5.3% | – |
| CapEx to OCF | -1.1% | -6.6% | -100.2% | -7.3% | -7.9% | -9.1% | -6.0% | – |
| CapEx to depreciation | 0.05 | 0.56 | 6.89 | 0.92 | 0.71 | 0.67 | 0.47 | – |
| Liquidity | ||||||||
| Current ratio | 1.86 | 2.76 | 1.19 | 2.34 | 1.51 | 2.68 | 0.56 | – |
| Quick ratio | 1.86 | 2.76 | 1.19 | 2.34 | 1.51 | 2.68 | 0.56 | – |
| Cash ratio | 1.09 | 1.84 | 0.79 | 1.89 | 1.13 | 1.94 | 0.24 | – |
| Working capital | $15.08M | $25.17M | $6.27M | $30.50M | $14.65M | $54.02M | -$9.90M | – |
| Net current asset value | -$57.42M | -$36.88M | -$54.83M | -$18.97M | -$12.76M | $6.24M | -$63.51M | – |
| Leverage | ||||||||
| Total debt | $47.45M | $36.41M | $35.23M | $25.00M | $9.99M | $15.93M | $23.81M | – |
| Net debt | $28.46M | $10.08M | $8.85M | -$18.17M | -$22.81M | -$46.38M | $18.34M | – |
| Debt / Equity | -19.25 | 1.74 | 7.69 | 1.21 | 0.51 | 0.39 | -0.11 | – |
| Debt ratio | 54.2% | 37.4% | 35.5% | 26.9% | 13.1% | 13.2% | 52.9% | – |
| Assets to equity | -35.49 | 4.66 | 21.64 | 4.51 | 3.86 | 2.94 | -0.20 | – |
| Long-term debt to assets | 54.2% | 37.4% | 35.5% | 26.9% | 13.1% | 13.2% | 52.9% | – |
| Long-term debt to equity | -19.25 | 1.74 | 7.69 | 1.21 | 0.51 | 0.39 | -0.11 | – |
| Total debt / Capitalization | 105.5% | 63.6% | 88.5% | 54.8% | 33.6% | 27.9% | -11.8% | – |
| Long-term debt / Capitalization | 105.5% | 63.6% | 88.5% | 54.8% | 33.6% | 27.9% | -11.8% | – |
| Net debt / EBITDA | -1.28 | -0.35 | -0.23 | 0.39 | 0.60 | 2.32 | -0.77 | – |
| Total debt / EBITDA | -2.14 | -1.27 | -0.93 | -0.53 | -0.26 | -0.80 | -0.99 | – |
| Cash flow to debt | -49.0% | -133.6% | -64.9% | -179.9% | -282.4% | -134.2% | -91.2% | – |
| Goodwill / Assets | 17.2% | 15.5% | 15.2% | 16.2% | 19.8% | 12.4% | 33.4% | – |
| Intangibles to total assets | 21.6% | 21.5% | 23.2% | 26.7% | 35.0% | 23.4% | 66.9% | – |
| Interest coverage | ||||||||
| EBIT / Interest expense | -3.61 | -4.18 | -4.34 | -6.27 | -9.08 | -3.02 | -8.89 | – |
| EBITDA / Interest expense | -2.88 | -3.48 | -3.99 | -5.82 | -8.38 | -2.63 | -7.96 | – |
| (EBITDA − CapEx) / Interest expense | -2.91 | -3.87 | -6.39 | -6.23 | -8.87 | -2.89 | -8.40 | – |
| Per share | ||||||||
| Revenue per share | 10.72 | 9.80 | 0.51 | 0.49 | 1.77 | 1.72 | 96.31 | – |
| EPS (basic) | -4.67 | -6.64 | -0.64 | -1.55 | -1.58 | -6.48 | -126.97 | – |
| EPS (diluted) | -4.67 | -6.64 | -0.64 | -1.55 | -1.58 | -6.48 | -126.97 | – |
| Book value per share | -0.30 | 2.87 | 0.05 | 0.27 | 0.64 | 1.55 | -883.18 | – |
| Tangible book value per share | -2.59 | -0.0040 | -0.19 | -0.05 | -0.22 | 0.48 | -1,001.35 | – |
| Cash per share | 2.30 | 3.62 | 0.27 | 0.56 | 1.07 | 2.35 | 21.45 | – |
| Operating cash flow per share | -2.82 | -6.69 | -0.24 | -0.58 | -0.92 | -0.80 | -85.23 | – |
| Free cash flow per share | -2.85 | -7.13 | -0.48 | -0.62 | -0.99 | -0.88 | -90.37 | – |
| CapEx per share | 0.03 | 0.44 | 0.24 | 0.04 | 0.07 | 0.07 | 5.14 | – |
| Valuation at period end | ||||||||
| Market cap | $54.09M | $4.45B | $3.25B | $1.89B | $2.86B | $116.73M | – | – |
| Enterprise value | $84.51M | $4.46B | $3.26B | $1.88B | $2.84B | $127.44M | – | – |
| P/S | 0.6x | 62.4x | 66.2x | 49.6x | 52.4x | 2.6x | – | – |
| P/B | -21.9x | 213x | 710x | 91.9x | 145x | 2.8x | – | – |
| P/TBV | -2.5x | -153,492x | -177x | -449x | -413x | 9.1x | – | – |
| P/OCF | -2.3x | -91.5x | -142x | -42.1x | -101x | -5.5x | – | – |
| EV/Sales | 1.0x | 62.5x | 66.3x | 49.3x | 52.1x | 2.8x | – | – |
| EV/OCF | -3.6x | -91.6x | -142x | -41.9x | -101x | -6.0x | – | – |
| Earnings yield | -65.2% | -0.96% | -1.6% | -3.5% | -1.5% | -56.1% | – | – |
| FCF yield | -43.5% | -1.2% | -1.4% | -2.5% | -1.1% | -20.0% | – | – |
| Shareholder yield | ||||||||
| Debt paydown yield | 0.04% | 0.00% | 0.00% | 1.5% | 1.6% | – | – | – |
| Cost structure | ||||||||
| R&D to revenue | 13.6% | 13.4% | 20.3% | 34.3% | 23.5% | 23.7% | 42.6% | – |
| SG&A to revenue | 98.9% | 112.8% | 137.3% | 160.8% | 92.7% | 76.5% | 124.8% | – |
| Stock-based comp to revenue | 4.7% | 9.3% | 10.9% | 15.6% | 9.1% | 8.1% | 0.69% | – |
| Per employee | ||||||||
| Total employees | 334 | 273 | 217 | 245 | 218 | 200 | 200 | 200 |
| Revenue per employee | $264.97K | $261.26K | $226.21K | $155.97K | $250.03K | $227.79K | $122.76K | – |
| Operating profit per employee | -$83.45K | -$126.37K | -$190.52K | -$206.48K | -$187.80K | -$114.67K | -$133.71K | – |
| Net income per employee | -$105.58K | -$157.26K | -$240.30K | -$267.13K | -$197.98K | -$327.24K | -$153.63K | – |
| Free cash flow per employee | -$70.45K | -$190.03K | -$211.01K | -$197.02K | -$139.74K | -$116.56K | -$115.18K | – |
| Growth | ||||||||
| Revenue 1Y growth | 24.1% | 45.3% | 28.5% | -29.9% | 19.6% | 85.6% | – | – |
| Revenue 3Y CAGR | 32.3% | 9.4% | 2.5% | 15.9% | – | – | – | – |
| Revenue 5Y CAGR | 14.2% | 23.8% | – | – | – | – | – | – |
| EBIT 1Y growth | 19.2% | 16.6% | 18.3% | -23.6% | -78.5% | 14.2% | – | – |
| EBITDA 1Y growth | 22.7% | 24.4% | 19.1% | -24.4% | -88.5% | 16.4% | – | – |
| Net income 1Y growth | 17.9% | 17.7% | 20.3% | -51.6% | 34.1% | -113.0% | – | – |
| Diluted EPS 1Y growth | 29.7% | -937.5% | 58.7% | 1.9% | 75.6% | 94.9% | – | – |
| Operating cash flow 1Y growth | 52.2% | -112.7% | 49.1% | -59.3% | -32.1% | 1.7% | – | – |
| Free cash flow 1Y growth | 54.6% | -13.3% | 5.1% | -58.4% | -30.7% | -1.2% | – | – |
| CapEx 1Y growth | -92.0% | -85.9% | 594.9% | 47.2% | 15.2% | 48.5% | – | – |
| CapEx 3Y CAGR | -57.2% | 13.0% | 127.6% | 36.0% | – | – | – | – |
| CapEx 5Y CAGR | -33.2% | 19.8% | – | – | – | – | – | – |
| Total assets 1Y growth | -10.0% | -1.9% | 6.7% | 22.1% | -37.1% | 168.8% | – | – |
| Total assets 3Y CAGR | -2.0% | 8.5% | -6.5% | 27.3% | – | – | – | – |
| Total assets 5Y CAGR | -6.3% | 16.6% | – | – | – | – | – | – |
| Total equity 1Y growth | -111.8% | 355.8% | -77.8% | 4.5% | -52.1% | 118.3% | -15.7% | – |
| Total equity 3Y CAGR | – | 1.9% | -51.9% | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.